In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...

Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...

A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...

Scientists at Northwestern University and at the University of California San Diego have developed a potent injectable therapy that the results of rodent studies showed can protect the heart from ...

New research discovers a potential path to prevent permanent scarring and heart failure following a myocardial infarction. A new study by investigators at Massachusetts General Hospital (MGH), a ...

Dr. Patrick Malecha (Medicine): A 69-year-old man with a history of myocardial infarction, ischemic cardiomyopathy, and an implantable cardioverter–defibrillator (ICD) was evaluated because of dyspnea ...

EMPACT-MI trial (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction, NCT04509674) is a multicenter, randomized, parallel-group, double-blind, ...

Alpha-1 adrenergic receptors (α1-ARs) are a subset of G protein-coupled receptors that play a pivotal role in cardiovascular homeostasis. While traditionally recognised for their involvement in ...

Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...

Heart failure now affects 7.4 million USA adults, driven by metabolic risks like obesity and diabetes. Learn how it has ...